elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33843083-080C1CA9-D384-473E-AB3D-9D431F0CE434
Q33843083-080C1CA9-D384-473E-AB3D-9D431F0CE434
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33843083-080C1CA9-D384-473E-AB3D-9D431F0CE434
Cerebellar Dysfunction in Multiple Sclerosis.
P2860
Q33843083-080C1CA9-D384-473E-AB3D-9D431F0CE434
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33843083-080C1CA9-D384-473E-AB3D-9D431F0CE434
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
03015db348f3e3e91b010013eb115bcc0d44e690
P2860
Alemtuzumab improves neurological functional systems in treatment-naive relapsing-remitting multiple sclerosis patients.